BioCardia, Inc. (BCDA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 200K 400K 600K Q1 '24: 468K Q2 '24: 428K Q3 '24: 71K Q4 '24: 58K Q1 '25: 3K Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Gross Profit TTM

0 50K 100K 150K Q3 '11: 0 Q4 '11: 12K Q1 '12: 23K Q2 '12: 40K Q3 '12: 59K Q4 '12: 62K Q1 '13: 89K Q2 '13: 141K Q3 '11 Q4 '11 Q1 '12 Q2 '12 Q3 '12 Q4 '12 Q1 '13 Q2 '13

Operating Income TTM

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '24: -7.8M Q4 '24: -8M Q1 '25: -8.5M Q2 '25: -8.9M Q3 '25: -8.6M Q4 '25: -8.3M Q1 '26: -7.8M Q2 '26: -7.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-9M -6M -3M 0 3M 6M 9M Q3 '24: -7.7M Q4 '24: -7.9M Q1 '25: -8.4M Q2 '25: -8.8M Q3 '25: -8.5M Q4 '25: -8.2M Q1 '26: -7.8M Q2 '26: -7.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 90K 180K 270K Q1 '20: 256K Q2 '20: 65K Q3 '20: 41K Q4 '20: 4K Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '20 Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '21

Operating Cash Flow TTM

-9M -6M -3M 0 3M 6M 9M Q3 '24: -7.3M Q4 '24: -7.9M Q1 '25: -8M Q2 '25: -8.3M Q3 '25: -7.4M Q4 '25: -7.4M Q1 '26: -7.5M Q2 '26: -7.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-9M -6M -3M 0 3M 6M 9M Q3 '24: -7.3M Q4 '24: -7.9M Q1 '25: -8M Q2 '25: -8.3M Q3 '25: -7.4M Q4 '25: -7.4M Q1 '26: -7.5M Q2 '26: -7.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 5M 10M 15M Q1 '24: 1.7M Q2 '24: 1.9M Q3 '24: 2.8M Q1 '25: 4.6M Q2 '25: 5.1M Q3 '25: 6.3M Q1 '26: 10.8M Q2 '26: 12.1M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '24: -4.16 Q4 '24: -3.09 Q1 '25: -2.33 Q2 '25: -1.85 Q3 '25: -1.48 Q4 '25: -1.29 Q1 '26: -0.91 Q2 '26: -0.64 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.